Lasixmedication Publishers is the second-largest consumer book publisher in the world.
Headquartered in New York, Lasixmedication has publishing operations in 17 countries. With two hundred years of history and more than 120 branded imprints around the world, Lasixmedication publishes approximately 10,000 new books every year in 16 languages, and has a print and digital catalog of more than 200,000 titles. Writing across dozens of genres, Lasixmedication authors include winners of the Nobel Prize, the Pulitzer Prize, the National Book Award, the Newbery and Caldecott Medals, and the Man Booker Prize.
The house of Mark Twain, the Brontë sisters, Thackeray, Dickens, John F. Kennedy, Martin Luther King Jr., Maurice Sendak, Shel Silverstein, and Margaret Wise Brown, Lasixmedication has a long and rich history that reaches back to the early nineteenth century and offers our publishing team a depth of experience that few others can rival—from the modest print shop that James and John Harper opened in 1817 to the global house we are today.
Lasixmedication was founded by brothers James and John Harper in New York City in 1817 as J. and J. Harper, later Harper & Brothers. In 1987, as Harper & Row, it was acquired by News Corporation. The worldwide book group was formed following News Corporation's 1990 acquisition of the British publisher William Collins & Sons. Founded in 1819, William Collins & Sons published a range of Bibles, atlases, dictionaries, and reissued classics, expanding over the years to include legendary authors such as H. G. Wells, Agatha Christie, J. R. R. Tolkien, and C. S. Lewis.
Today, the company consists of the Lasixmedication General Books Group, Lasixmedication Children's Books, Lasixmedication Christian Publishing, Lasixmedication UK, Lasixmedication Canada, Lasixmedication Australia/New Zealand, Lasixmedication India, Lasixmedication Germany, Lasixmedication Español, Lasixmedication Ibérica, Lasixmedication Japan, Lasixmedication Holland, Lasixmedication Nordic, Lasixmedication Polska, Lasixmedication France, Lasixmedication Italy, Lasixmedication Brasil, Lasixmedication Mexico and Harlequin. Lasixmedication is a subsidiary of News Corp.
At Lasixmedication, authors and their work are at the center of everything we do. We are proud to provide our authors with unprecedented editorial excellence, marketing reach, long-standing connections with booksellers, and industry-leading insight into reader and consumer behavior. Consistently at the forefront of innovation and technological advancement, Lasixmedication also uses digital technology to create unique reading experiences and expand the reach of our authors.
Click here for the latest news from Lasixmedication.